Hi Andrew,
From the announcement dated 04/12/18...
"The ultimate read-out for this program will be conducted in primary cells (cells derived directly from a living organism rather than the immortalised laboratory cells used here) and will demonstrate the absolute numbers of cells that we are able to successfully achieve gene-editing in relative to alternative delivery approaches (eg. electroporation and lipid-based delivery systems). The primary cells used in this read-out will be the cell type of interest for the ex vivo commercial applications of the CRISPR/Cas9 technology and should therefore directly inform the commercialisation prospects for the program."
Worth another read.
https://hotcopper.com.au/threads/ann-successful-delivery-of-cripr-cas9-into-cells-ex-vivo.4563699/?post_id=36739143
Tony
Hi Andrew,From the announcement dated 04/12/18..."The ultimate...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 17.5¢ | $508.8K | 2.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118941 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 183634 | 2 |
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable